An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain

Pain ◽  
1991 ◽  
Vol 45 (2) ◽  
pp. 149-153 ◽  
Author(s):  
Perry G. Fine ◽  
Marco Marcus ◽  
Just A. De Boer ◽  
Bianca Van der Oord
Keyword(s):  
Cancer Pain ◽  
Open Label ◽  
Fentanyl Citrate ◽  
Open Label Study ◽  
Label Study ◽  
Breakthrough Cancer Pain ◽  
Oral Transmucosal Fentanyl Citrate

Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain

2015 ◽  
Vol 23 (7) ◽  
pp. 2135-2143 ◽  
Author(s):  
Andrew Davies ◽  
Ulrich R. Kleeberg ◽  
Jerzy Jarosz ◽  
Sebastiano Mercadante ◽  
Philippe Poulain ◽  
...  
Keyword(s):  
Cancer Pain ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Patient Functioning ◽  
Breakthrough Cancer Pain ◽  
Patients With Cancer ◽  
Fentanyl Buccal Tablet ◽  
Buccal Tablet

Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients

2012 ◽  
Vol 8 (4) ◽  
pp. 243-252 ◽  
Author(s):  
Kyung Hee Lee, MD ◽  
Min Kyoung Kim, MD ◽  
Myung Soo Hyun, MD ◽  
Jin Young Kim, MD ◽  
Keon Uk Park, MD ◽  
...  
Keyword(s):  
Cancer Pain ◽  
Pain Treatment ◽  
Clinical Effectiveness ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Breakthrough Cancer Pain ◽  
Korean Patients

Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head-to-Head, Randomized, Open-Label Study

Pain Practice ◽  
2013 ◽  
Vol 14 (1) ◽  
pp. 32-42 ◽  
Author(s):  
Efklidis Raptis ◽  
Athina Vadalouca ◽  
Evmorfia Stavropoulou ◽  
Eriphili Argyra ◽  
Aikaterini Melemeni ◽  
...  
Keyword(s):  
Cancer Pain ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document